Table 10.
Skeletal‐related events in patients with bone metastases/lesions by malignancy type and by bisphosphonate treatment status: data from the detailed questionnaire
| All BM patients (N = 8768) | Currently treated (n = 5133) | Previously treated (n = 1699) | Treatment planned (n = 575) | Will never be treated (n = 1361) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ST | HM | ST | HM | ST | HM | ST | HM | ST | HM | |
| All SREs (%) | 22 | 41 | 21 | 45 | 25 | 40 | 10 | 32 | 16 | 25 |
| n | 1592 | 646 | 1043 | 386 | 303 | 188 | 51 | 19 | 189 | 47 |
| Radiotherapy to bone | 62 | 28 | 63 | 27 | 63 | 28 | 57 | 20 | 55 | 47 |
| Pathologic fracture | 30 | 62 | 31 | 63 | 29 | 62 | 31 | 74 | 30 | 53 |
| Spinal cord compression | 15 | 19 | 14 | 18 | 16 | 24 | 12 | 16 | 20 | 9 |
| Surgery to bone | 7 | 8 | 6 | 9 | 6 | 7 | 4 | 16 | 12 | 0 |
BM, bone metastases/bone lesions, HM, haematological malignancy; SRE, skeletal‐related event; ST, solid tumour.
Some patients had multiple SREs.